Navigation Links
AOBO's Products Included in China's Essential Drug List
Date:8/26/2009

NEW YORK, Aug. 26 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that sixty one of its products have been included in China's Essential Drug List ("EDL"). The Company currently manufactures and markets six of the sixty one products, including one of the Company's leading products, Jinji Yimucao. Additionally, the Company is actively exploring marketing other AOBO products included in the EDL.

China's Ministry of Health ("MOH") released the EDL on August 18, 2009. After a rigorous selection process, an expert evaluation group selected three hundred and seven "essential medicines" from tens of thousands of products. Inclusion in the EDL ensures that products deemed to be essential medicines are available to the public at appropriate dosages and at affordable rates, at all times. Inclusion in the EDL also ensures inclusion in the National Medical Insurance Catalog, which reimburses manufacturers.

Mr. Tony Liu, Chairman and Chief Executive Officer of American Oriental Bioengineering, commented, "We believe we are well-positioned in the context of China's healthcare reform, and we are aligned with the PRC's overall efforts to enhance medical care and coverage nationally. We are honored to have sixty one products included in China's Essential Drug List, and today's announcement speaks to our commitment to efficacy and high quality. Our status as a designated branded supplier will boost distributor confidence and retail sales efforts. Going forward, AOBO will continue to be aligned with China's healthcare efforts as we maintain our vision and dedication to improving consumer health in China."

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission, including the Form 10-K for the year ended December 31, 2008, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

    For more information, please contact:

    Integrated Corporate Relations, Inc.
     Ashley M. Ammon
     Tel: +1-203-682-8208

'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
2. China Biologic Products Schedules 2009 Second Quarter Earnings Conference Call
3. Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
4. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
5. Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting
6. avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign
7. China Biologic Products Hosts its First Forum for Strategy and Development
8. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
9. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
10. International Products Corp.s Lab Offers Filter Membrane Compatibility and Studies
11. CQ Forum on Biosimilar Biological Products - Wed., June 17, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... (AI) and leading supplier of Semantic Graph Database technology, today announced the availability ... release of Cloudera Enterprise through the Cloudera Certified Technology Program (CCPT). ...
(Date:2/8/2016)... , Feb. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that its new ... specialty pharmacy resource–user-centric, story-driven, knowledge-based and mobile-friendly. Visit ... ... ... "The goal was ...
(Date:2/6/2016)... ... 2016 , ... Contact:, Abby Mitchell, Communications Manager, Phone: 703-448-9062 ... Teacher Training Program , Bite of Science Dinner Event to Strengthen Science Teaching ... Education (CEE) will sponsor a Bite of Science professional enrichment session, cost-free, for ...
(Date:2/5/2016)... -- On Thursday, February 11, 2-1-1 San Diego ... and disaster services, and the Community Information Exchange ... coordination and service delivery for the community to better ... better connect service providers to the information they can ... has handled more than 2.5 million connections ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... , Feb. 2, 2016   Parabon NanoLabs ... the U.S. Army Research Office and the Defense ... and sensitivity of the company,s Snapshot Kinship ... Mission and, more generally, defense-related DNA forensics.  Although ... capabilities (predicting appearance and ancestry from DNA evidence), ...
(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
Breaking Biology News(10 mins):